- Home
- Stacks
- Claim reviews
- Epitalon + MOTS-c
Fact-checked by the Peptide Authority Editorial Board · Last reviewed:
Claim review
Epitalon + MOTS-c — claim review
Marketed as the headline 'cellular longevity stack' in biohacker circles — pineal-peptide telomerase activation plus mitochondrial-derived metabolic signalling. Mechanistic story is interesting; the human outcome evidence does not match the marketing.
What people claim
- “Reverses biological ageing at the cellular level”
- “Extends lifespan 20-30%”
- “Restores youthful telomere length and mitochondrial function”
Evidence honestly
Epitalon: telomerase-activation effects in cell cultures and rodents; human evidence from Russian groups not independently replicated. MOTS-c: preclinical metabolic and exercise-mimetic data; no Phase 3 longevity trial.
Safer alternatives
- Aerobic + resistance exercise — the evidence-based healthspan intervention.
- Mediterranean-style diet, adequate sleep, social engagement.
- NHS over-40 Health Check + cancer screening — the highest-impact UK longevity intervention.
Frequently asked questions
- Does Epitalon + MOTS-c extend human lifespan?
- No randomised human trial demonstrates this. Both have mechanistic-interest data; neither has Phase 3 longevity outcome trials. Combination has zero human trial support.
- Is Epitalon evidence-based?
- Most positive human data comes from a single Russian research group, with limited independent Western replication. Telomere-length changes in cell cultures do not equal lifespan extension in humans.
- Is there a cancer risk with telomerase activation?
- Theoretical, not resolved. Sustained telomerase activation in cells with pre-existing genetic damage is mechanistically capable of facilitating malignant transformation. Long-term human cancer surveillance does not exist for Epitalon use.
- Are these legal in the UK?
- Neither is a licensed UK medicine. Sale with human-use longevity claims engages UK medicines regulation.
- What is the honest UK position?
- These are unlicensed compounds with weak human evidence and unresolved long-term safety. The strongest-evidence longevity intervention available in the UK is the routine NHS health check + lifestyle modification + cancer screening.